Logo - springer
Slogan - springer
Medicine - Orthopedics | HSS Journal - incl. option to publish open access

Orthopedics

Home > Medicine > Orthopedics
HSS Journal ®

HSS Journal ®

The Musculoskeletal Journal of Hospital for Special Surgery

Editor-in-Chief: Charles N. Cornell, MD

ISSN: 1556-3316 (print version)
ISSN: 1556-3324 (electronic version)

Journal no. 11420

$99.00 Personal Rate e-only for the Americas
Get Subscription

Online subscription, valid from January through December of current calendar year

Immediate access to this year's issues via SpringerLink

1 Volume(-s) with 3 issue(-s) per annual subscription

Automatic annual renewal

More information: >> FAQs // >> Policy

Instructions for Authors

Note from the Managing Editor 

If you have already registered on Editorial Manager, please use your provided username and password and log in as 'Author' to track your manuscript or to submit a new manuscript. (please do not register again as you will then be unable to track your manuscript). Otherwise, if you are a new author, please click the 'Register' button and enter the requested information. Upon successful registration you will be sent an e-mail with instructions to verify your registration.
Keep copies of your word-processing and figure files. You may want to revise the manuscript during the review process and you will need the original files if your manuscript requires revisions. If you are unable to submit your manuscript via Editorial Manager, please contact the editorial office:
Natanya Gayle, MPH, Managing Editor
Education Division
Hospital for Special Surgery
535 East 70th Street
New York, NY 10021
Telephone: (646) 797–8509
E-mail: gaylen@hss.edu

Editorial procedure 

Double-blind peer review

This journal follows a double-blind reviewing procedure. Authors are therefore requested to submit:
  • A blinded manuscript without any author names and affiliations in the text or on the title page. Self-identifying citations and references in the article text should be avoided.
  • A separate title page, containing title, all author names, affiliations, and the contact information of the corresponding author. Any acknowledgements, disclosures, or funding information should also be included on this page.

Manuscript Submission 

Manuscript Submission

Submission of a manuscript implies: that the work described has not been published before; that it is not under consideration for publication anywhere else; that its publication has been approved by all co-authors, if any, as well as by the responsible authorities – tacitly or explicitly – at the institute where the work has been carried out. The publisher will not be held legally responsible should there be any claims for compensation.

Permissions

Authors wishing to include figures, tables, or text passages that have already been published elsewhere are required to obtain permission from the copyright owner(s) for both the print and online format and to include evidence that such permission has been granted when submitting their papers. Any material received without such evidence will be assumed to originate from the authors.

Online Submission

Please follow the hyperlink “Submit online” on the right and upload all of your manuscript files following the instructions given on the screen.

Consent for use of photographs

If your paper contains a patient photograph please be sure to have obtained consent for the photo to be reused and submit a photography consent form which you can download from a tab on the right hand side of this page.

Ethical Standards 

HSS Journal adheres to the ethical standards outlined by the Committee on Publication Ethics Guidelines (COPE) and the Surgery Journal Editors Group (SJEG). Authors are encouraged to familiarize themselves with the COPE guidelines by visiting http://publicationethics.org/.
As per the consensus statement of SJEG, any conflicts of interest or financial relationships that existed within the past 12 months and which may influence the content of any submitted article must be disclosed. These standards ensure compliance with ACCME regulations. Commercial interest include any entity producing, marketing, re-selling or distributing health care goods or services consumed by or used on patients. Provision of clinical service directly to patients is not considered a commercial interest. Financial relationships are those in which individuals or institutions benefit by receiving salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest ( e.g. stocks, bonds, stock options excluding diversified mutual funds) or other financial benefit. These benefits are usually associated with employment, independent contracts consulting, speaking and teaching, membership on advisory or review panels, board memberships and any other activity from which remuneration is expected. Financial relationships of a spouse or partner must also be disclosed. Conflicts of Interest arise when an author has an opportunity to influence the content of manuscripts regarding products or services of a commercial interest with which he or she has a financial interest.

Conflict of Interest Disclosure 

When authors submit a manuscript, they are responsible for disclosing all financial and personal relationships that might bias their work. To prevent ambiguity, authors must state explicitly whether potential conflicts do or do not exist. Each author must indicate whether or not they have a financial relationship with the organization that sponsored the research. For each source of funds, both the research funder and the grant number should be given.
Potential conflicts of interest exist when an author is related to a for-profit company or institution in any of the following ways:
1. Employment
2. Consultancies in the last 3 years (please list)
3. Honoraria in the last 3 years (please list)
4. Stock ownership/ options other than mutual funds (current; please list)
5. Expert testimony in the last 3 years (please list)
6. Grants received in the last 3 years (please list)
7. Grants pending (please list)
8. Patents received
9. Patents pending
10. Royalties (describe)
11. Other relationships (please specify)
Conflict of interest statements should be present on every manuscript before the References section. The statement should mention each author separately by name.
Recommended wording is as follows:
Author X declares that he has no conflict of interest.
Author Y has received research grants from Drug Company A.
Author Z has received a speaker honorarium from Drug Company B and owns stock in Drug Company C.
If multiple authors declare no conflict, this can be done in one sentence:
Author X, Author Y and Author Z declare that they have no conflict of interest.
The journal also abides by the Uniform Requirements for Manuscripts Submitted to Biomedical Journals of the International Committee of Medical Journal Editors. It is mandatory for all authors to complete a ICMJE uniform disclosure form (PDF format) upon submission which will be hosted electronically and accessible through the online version of any accepted paper.
To download this form, please follow the hyperlink below.
Follow the below link for Springer's Conflict of Interest Statement:

Informed Consent 

For studies with human subjects, please include the following statement before the References section:
'All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000 (5). Informed consent was obtained from all patients for being included in the study.'
Any experimental protocol must be approved, and owing to US regulations (the recent Health Insurance Portability and Accountability Act - HIPAA) even studies without any experimental protocol merely reporting patients or patient material require approval; these regulations require review for any studies involving patient identity, including retrospective chart, radiographic reviews, or removed tissues or materials.
If any identifying information about patients is included in the article, the following sentence should also be included:
'Additional informed consent was obtained from all patients for which identifying information is included in this article.'
Follow the below link for Springer's Informed Consent Statement:

Animal Studies 

For studies with animals, include the following sentence in the manuscript before the References section:
'All institutional and national guidelines for the care and use of laboratory animals were followed.'
If the authors did not carry out animal and/or human studies as part of their article they must include the following statement in the manuscript before the References section:
'No animal or human studies were carried out by the authors for this article'
The editors reserve the right to reject manuscripts that do not comply with the above-mentioned requirements. The author will be held responsible for false statements or failure to fulfill the above-mentioned requirements
Follow the below link for Springer's Animal and Human Rights Statement

Types of Articles 

HSS Journal publishes a variety of types of articles:
  • Clinical Research articles describing the latest evidence on the treatment, diagnosis, prognosis, or cost-effectiveness of musculoskeletal disorders
  • Basic Research articles exploring mechanisms of musculoskeletal disorders and/or their treatment
  • Survey Articles including systematic reviews or meta-analyses. General reviews are usually not acceptable.
  • Surgical Techniques describing new approaches or methods
  • Case Reports describing situations with unusual diagnostic dilemma or unanticipated Complications. These include Radiology and Imaging as well as Electrodiagnostic Corners.
  • Rheumatology Radiology-Pathology Conferences presenting single cases as an unknown
  • Letters to the Editor

Guidelines for Articles Types 

The editorial board of the HSS Journal has requested that authors follow a question driven style in preparation of manuscripts. As a reference, authors are referred to the work of R.A. Brand, M.D. (Clin Orthop Relat Res. 2008;466:239-247) for assistance in preparing manuscripts in the question driven style.
CLINICAL RESEARCH ARTICLES (Fewer than 3000 words) These should be organized as a question-driven text; authors should pose 2-4 specific questions or hypotheses or purposes and then have corresponding paragraphs in Results and Discussion.
All observational studies reporting patients should provide all relevant information following the Strobe guidelines. Manuscripts reporting randomized controlled trials must incorporate the Consort guidelines. We ask that authors include a complete copy of the checklist and flow chart as part of their submission for randomized controlled trials (RCTs). The form can be downloaded via (http://www.consort-statement.org/consort-statement/overview0/). Also, please select and include a citation from the following one of the citations from http://www.consort-statement.org/consort-statement/citing-and-using-consort
BASIC RESEARCH ARTICLES (Fewer than 3000 words) These should be organized as a question-driven text; authors should pose 2-4specific questions or hypotheses or purposes and then have Corresponding paragraphs in Results and Discussion. The clinical relevance should be clear from the Abstract, Introduction, and Discussion. Click for template.
SURVEY ARTICLES (Fewer than 5000 words). We encourage submission of survey articles but request that they be systematic reviews or meta-analyses. We discourage submission of non-focused general reviews. Survey articles must have Introduction and Discussion sections, but the intervening sections may vary depending upon the particulars of the topic. Systematic reviews must follow the Cochrane Guidelines and meta-analyses must follow the QUORUM Guidelines. Systematic reviews should include a flowchart of the search strategies and criteria as advocated by the QUORUM guidelines.
SURGICAL TECHNIQUE ARTICLES (Fewer than 2000 words).
We encourage the submission of surgical technique articles reporting new approaches. They should contain an
Introduction, Technique, Materials and Methods, Results, and Discussion. The Introduction should include the need and rationale for the new technique. The technique should be described succinctly, yet with enough detail to be used by others. To validate the technique some results must be included in the text. These results must be appropriate for the problem being addressed and include sufficient numbers of patients, followup times, and assessment methods to warrant use by other physicians. The Discussion should be short and describe the advantages and disadvantages of the technique compared with previous techniques. We encourage authors to submit short video clips of unique aspects of the surgery (see instructions for submitting electronic supplementary material).
CASE REPORTS (Fewer than 2000 words).
We receive a large number of case reports and typically only accept those of exceptional teaching value. We must be extremely selective in choosing case reports for publication. Appropriate case reports might include the following:
  • a diagnostic dilemma
  • unusual manifestations of disease processes
  • an unusual treatment challenge
  • unanticipated early failures or complications of some treatment
We typically do not accept cases in which two entities are associated since conditions may occur
coincidentally, rather than causally. Authors must include a representative literature review.
RHEUMATOLOGY-RADIOLOGY-PATHOLOGY CONFERENCE (Fewer than 2000 words).
These are case reports presented as unknowns. They have a required structure.
LETTERS TO THE EDITOR (Fewer than 500 words)
ARTICLES DEDICATED TO PRESERVATION OF THE UNIQUE HISTORY OF HOSPITAL FOR SPECIAL SURGERY. Please contact the Editor-In-Chief prior to submission.

Title page 

Title Page

The title page should include:
  • The name(s) of the author(s)
  • A concise and informative title
  • The affiliation(s) and address(es) of the author(s)
  • The e-mail address, and telephone number(s) of the corresponding author
  • If available, the 16-digit ORCID of the author(s)

Abstract

Please provide an abstract of 150 to 250 words. The abstract should not contain any undefined abbreviations or unspecified references.

Keywords

Please provide 4 to 6 keywords which can be used for indexing purposes.

Text 

Text Formatting

Manuscripts should be submitted in Word.
  • Use a normal, plain font (e.g., 10-point Times Roman) for text.
  • Use italics for emphasis.
  • Use the automatic page numbering function to number the pages.
  • Do not use field functions.
  • Use tab stops or other commands for indents, not the space bar.
  • Use the table function, not spreadsheets, to make tables.
  • Use the equation editor or MathType for equations.
  • Save your file in docx format (Word 2007 or higher) or doc format (older Word versions).

Headings

Please use no more than three levels of displayed headings.

Abbreviations

Abbreviations should be defined at first mention and used consistently thereafter.

Footnotes

Footnotes can be used to give additional information, which may include the citation of a reference included in the reference list. They should not consist solely of a reference citation, and they should never include the bibliographic details of a reference. They should also not contain any figures or tables.
Footnotes to the text are numbered consecutively; those to tables should be indicated by superscript lower-case letters (or asterisks for significance values and other statistical data). Footnotes to the title or the authors of the article are not given reference symbols.
Always use footnotes instead of endnotes.

Acknowledgments

Acknowledgments of people, grants, funds, etc. should be placed in a separate section on the title page. The names of funding organizations should be written in full.

References 

Citation

Reference citations in the text should be identified by numbers in square brackets. Some examples:
1. Negotiation research spans many disciplines [3].
2. This result was later contradicted by Becker and Seligman [5].
3. This effect has been widely studied [1-3, 7].

Reference list

The list of references should only include works that are cited in the text and that have been published or accepted for publication. Personal communications and unpublished works should only be mentioned in the text. Do not use footnotes or endnotes as a substitute for a reference list.
The entries in the list should be numbered in alphabetic order.
  • Journal article
    Smith JJ. The world of science. Am J Sci. 1999;36:234–5.
  • Article by DOI
    Slifka MK, Whitton JL. Clinical implications of dysregulated cytokine production. J Mol Med. 2000; doi:10.1007/s001090000086
  • Book
    Blenkinsopp A, Paxton P. Symptoms in the pharmacy: a guide to the management of common illness. 3rd ed. Oxford: Blackwell Science; 1998.
  • Book chapter
    Wyllie AH, Kerr JFR, Currie AR. Cell death: the significance of apoptosis. In: Bourne GH, Danielli JF, Jeon KW, editors. International review of cytology. London: Academic; 1980. pp. 251–306.
  • Online document
    Doe J. Title of subordinate document. In: The dictionary of substances and their effects. Royal Society of Chemistry. 1999. http://www.rsc.org/dose/title of subordinate document. Accessed 15 Jan 1999.
Always use the standard abbreviation of a journal’s name according to the ISSN List of Title Word Abbreviations, see
If you are unsure, please use the full journal title.
For authors using EndNote, Springer provides an output style that supports the formatting of in-text citations and reference list.

Please note:

  • The reference-style presented above complies with the modified AMA style.

Tables 

  • All tables are to be numbered using Arabic numerals.
  • Tables should always be cited in text in consecutive numerical order.
  • For each table, please supply a table caption (title) explaining the components of the table.
  • Identify any previously published material by giving the original source in the form of a reference at the end of the table caption.
  • Footnotes to tables should be indicated by superscript lower-case letters (or asterisks for significance values and other statistical data) and included beneath the table body.

Artwork and Illustrations Guidelines 

Electronic Figure Submission

  • Supply all figures electronically.
  • Indicate what graphics program was used to create the artwork.
  • For vector graphics, the preferred format is EPS; for halftones, please use TIFF format. MSOffice files are also acceptable.
  • Vector graphics containing fonts must have the fonts embedded in the files.
  • Name your figure files with "Fig" and the figure number, e.g., Fig1.eps.

Line Art

Line BW
  • Definition: Black and white graphic with no shading.
  • Do not use faint lines and/or lettering and check that all lines and lettering within the figures are legible at final size.
  • All lines should be at least 0.1 mm (0.3 pt) wide.
  • Scanned line drawings and line drawings in bitmap format should have a minimum resolution of 1200 dpi.
  • Vector graphics containing fonts must have the fonts embedded in the files.

Halftone Art

Halftone gray color
  • Definition: Photographs, drawings, or paintings with fine shading, etc.
  • If any magnification is used in the photographs, indicate this by using scale bars within the figures themselves.
  • Halftones should have a minimum resolution of 300 dpi.

Combination Art

Combined
  • Definition: a combination of halftone and line art, e.g., halftones containing line drawing, extensive lettering, color diagrams, etc.
  • Combination artwork should have a minimum resolution of 600 dpi.

Color Art

  • Color art is free of charge for online publication.
  • If black and white will be shown in the print version, make sure that the main information will still be visible. Many colors are not distinguishable from one another when converted to black and white. A simple way to check this is to make a xerographic copy to see if the necessary distinctions between the different colors are still apparent.
  • If the figures will be printed in black and white, do not refer to color in the captions.
  • Color illustrations should be submitted as RGB (8 bits per channel).

Figure Lettering

  • To add lettering, it is best to use Helvetica or Arial (sans serif fonts).
  • Keep lettering consistently sized throughout your final-sized artwork, usually about 2–3 mm (8–12 pt).
  • Variance of type size within an illustration should be minimal, e.g., do not use 8-pt type on an axis and 20-pt type for the axis label.
  • Avoid effects such as shading, outline letters, etc.
  • Do not include titles or captions within your illustrations.

Figure Numbering

  • All figures are to be numbered using Arabic numerals.
  • Figures should always be cited in text in consecutive numerical order.
  • Figure parts should be denoted by lowercase letters (a, b, c, etc.).
  • If an appendix appears in your article and it contains one or more figures, continue the consecutive numbering of the main text. Do not number the appendix figures,
    "A1, A2, A3, etc." Figures in online appendices (Electronic Supplementary Material) should, however, be numbered separately.

Figure Captions

  • Each figure should have a concise caption describing accurately what the figure depicts. Include the captions in the text file of the manuscript, not in the figure file.
  • Figure captions begin with the term Fig. in bold type, followed by the figure number, also in bold type.
  • No punctuation is to be included after the number, nor is any punctuation to be placed at the end of the caption.
  • Identify all elements found in the figure in the figure caption; and use boxes, circles, etc., as coordinate points in graphs.
  • Identify previously published material by giving the original source in the form of a reference citation at the end of the figure caption.

Figure Placement and Size

  • Figures should be submitted separately from the text, if possible.
  • When preparing your figures, size figures to fit in the column width.
  • For most journals the figures should be 39 mm, 84 mm, 129 mm, or 174 mm wide and not higher than 234 mm.
  • For books and book-sized journals, the figures should be 80 mm or 122 mm wide and not higher than 198 mm.

Permissions

If you include figures that have already been published elsewhere, you must obtain permission from the copyright owner(s) for both the print and online format. Please be aware that some publishers do not grant electronic rights for free and that Springer will not be able to refund any costs that may have occurred to receive these permissions. In such cases, material from other sources should be used.

Accessibility

In order to give people of all abilities and disabilities access to the content of your figures, please make sure that
  • All figures have descriptive captions (blind users could then use a text-to-speech software or a text-to-Braille hardware)
  • Patterns are used instead of or in addition to colors for conveying information (colorblind users would then be able to distinguish the visual elements)
  • Any figure lettering has a contrast ratio of at least 4.5:1

Electronic Supplementary Material 

Springer accepts electronic multimedia files (animations, movies, audio, etc.) and other supplementary files to be published online along with an article or a book chapter. This feature can add dimension to the author's article, as certain information cannot be printed or is more convenient in electronic form.
Before submitting research datasets as electronic supplementary material, authors should read the journal’s Research data policy. We encourage research data to be archived in data repositories wherever possible.

Submission

  • Supply all supplementary material in standard file formats.
  • Please include in each file the following information: article title, journal name, author names; affiliation and e-mail address of the corresponding author.
  • To accommodate user downloads, please keep in mind that larger-sized files may require very long download times and that some users may experience other problems during downloading.

Audio, Video, and Animations

  • Aspect ratio: 16:9 or 4:3
  • Maximum file size: 25 GB
  • Minimum video duration: 1 sec
  • Supported file formats: avi, wmv, mp4, mov, m2p, mp2, mpg, mpeg, flv, mxf, mts, m4v, 3gp

Text and Presentations

  • Submit your material in PDF format; .doc or .ppt files are not suitable for long-term viability.
  • A collection of figures may also be combined in a PDF file.

Spreadsheets

  • Spreadsheets should be submitted as .csv or .xlsx files (MS Excel).

Specialized Formats

  • Specialized format such as .pdb (chemical), .wrl (VRML), .nb (Mathematica notebook), and .tex can also be supplied.

Collecting Multiple Files

  • It is possible to collect multiple files in a .zip or .gz file.

Numbering

  • If supplying any supplementary material, the text must make specific mention of the material as a citation, similar to that of figures and tables.
  • Refer to the supplementary files as “Online Resource”, e.g., "... as shown in the animation (Online Resource 3)", “... additional data are given in Online Resource 4”.
  • Name the files consecutively, e.g. “ESM_3.mpg”, “ESM_4.pdf”.

Captions

  • For each supplementary material, please supply a concise caption describing the content of the file.

Processing of supplementary files

  • Electronic supplementary material will be published as received from the author without any conversion, editing, or reformatting.

Accessibility

In order to give people of all abilities and disabilities access to the content of your supplementary files, please make sure that
  • The manuscript contains a descriptive caption for each supplementary material
  • Video files do not contain anything that flashes more than three times per second (so that users prone to seizures caused by such effects are not put at risk)

Scientific style 

  • Please always use internationally accepted signs and symbols for units (SI units).
  • Nomenclature: Insofar as possible, authors should use systematic names similar to those used by Chemical Abstract Service or IUPAC.
  • Genus and species names should be in italics.
  • Generic names of drugs and pesticides are preferred; if trade names are used, the generic name should be given at first mention.

Abbreviations, drug/product names, and digits 

Please use the standard abbreviations and units listed in Scientific Style and Format: The CBE Manual for Authors, Editors, and Publishers, Sixth Edition (Reston, Va., Council of Biology Editors, 1994). The first time an abbreviated term is used, spell it out in full and follow with the abbreviation in parentheses – for example: ultrasound (US).
Generic names for drugs and chemicals should be used the first time the drug or chemical is mentioned in the text and, preferably, thereafter. The first reference to a drug or chemical in the text should be followed by the manufacturer name, city, state or province, and country – and, if you wish, the trade name – in parentheses.
Please express digits as numerals except when they are the first word in a sentence. Decimals should be written in North American format. Express units of measurement in the metric system whenever possible, and abbreviate them when used with numbers.

Research Data Policy 

The journal encourages authors, where possible and applicable, to deposit data that support the findings of their research in a public repository. Authors and editors who do not have a preferred repository should consult Springer Nature’s list of repositories and research data policy.
General repositories - for all types of research data - such as figshare and Dryad may also be used.
Datasets that are assigned digital object identifiers (DOIs) by a data repository may be cited in the reference list. Data citations should include the minimum information recommended by DataCite: authors, title, publisher (repository name), identifier.
Springer Nature provides a research data policy support service for authors and editors, which can be contacted at researchdata@springernature.com.
This service provides advice on research data policy compliance and on finding research data repositories. It is independent of journal, book and conference proceedings editorial offices and does not advise on specific manuscripts.

Ethical Responsibilities of Authors 

This journal is committed to upholding the integrity of the scientific record. As a member of the Committee on Publication Ethics (COPE) the journal will follow the COPE guidelines on how to deal with potential acts of misconduct.
Authors should refrain from misrepresenting research results which could damage the trust in the journal, the professionalism of scientific authorship, and ultimately the entire scientific endeavour. Maintaining integrity of the research and its presentation can be achieved by following the rules of good scientific practice, which include:
  • The manuscript has not been submitted to more than one journal for simultaneous consideration.
  • The manuscript has not been published previously (partly or in full), unless the new work concerns an expansion of previous work (please provide transparency on the re-use of material to avoid the hint of text-recycling (“self-plagiarism”)).
  • A single study is not split up into several parts to increase the quantity of submissions and submitted to various journals or to one journal over time (e.g. “salami-publishing”).
  • No data have been fabricated or manipulated (including images) to support your conclusions
  • No data, text, or theories by others are presented as if they were the author’s own (“plagiarism”). Proper acknowledgements to other works must be given (this includes material that is closely copied (near verbatim), summarized and/or paraphrased), quotation marks are used for verbatim copying of material, and permissions are secured for material that is copyrighted.
    Important note: the journal may use software to screen for plagiarism.
  • Consent to submit has been received explicitly from all co-authors, as well as from the responsible authorities - tacitly or explicitly - at the institute/organization where the work has been carried out, before the work is submitted.
  • Authors whose names appear on the submission have contributed sufficiently to the scientific work and therefore share collective responsibility and accountability for the results.
  • Authors are strongly advised to ensure the correct author group, corresponding author, and order of authors at submission. Changes of authorship or in the order of authors are not accepted after acceptance of a manuscript.
  • Adding and/or deleting authors at revision stage may be justifiably warranted. A letter must accompany the revised manuscript to explain the role of the added and/or deleted author(s). Further documentation may be required to support your request.
  • Requests for addition or removal of authors as a result of authorship disputes after acceptance are honored after formal notification by the institute or independent body and/or when there is agreement between all authors.
  • Upon request authors should be prepared to send relevant documentation or data in order to verify the validity of the results. This could be in the form of raw data, samples, records, etc. Sensitive information in the form of confidential proprietary data is excluded.
If there is a suspicion of misconduct, the journal will carry out an investigation following the COPE guidelines. If, after investigation, the allegation seems to raise valid concerns, the accused author will be contacted and given an opportunity to address the issue. If misconduct has been established beyond reasonable doubt, this may result in the Editor-in-Chief’s implementation of the following measures, including, but not limited to:
  • If the article is still under consideration, it may be rejected and returned to the author.
  • If the article has already been published online, depending on the nature and severity of the infraction, either an erratum will be placed with the article or in severe cases complete retraction of the article will occur. The reason must be given in the published erratum or retraction note. Please note that retraction means that the paper is maintained on the platform, watermarked "retracted" and explanation for the retraction is provided in a note linked to the watermarked article.
  • The author’s institution may be informed.

After acceptance 

Upon acceptance of your article you will receive a link to the special Author Query Application at Springer’s web page where you can sign the Copyright Transfer Statement online and indicate whether you wish to order OpenChoice, offprints, or printing of figures in color.
Once the Author Query Application has been completed, your article will be processed and you will receive the proofs.

Copyright transfer

Authors will be asked to transfer copyright of the article to the Publisher (or grant the Publisher exclusive publication and dissemination rights). This will ensure the widest possible protection and dissemination of information under copyright laws.

Offprints

Offprints can be ordered by the corresponding author.

Color illustrations

Online publication of color illustrations is free of charge. For color in the print version, authors will be expected to make a contribution towards the extra costs.

Proof reading

The purpose of the proof is to check for typesetting or conversion errors and the completeness and accuracy of the text, tables and figures. Substantial changes in content, e.g., new results, corrected values, title and authorship, are not allowed without the approval of the Editor.
After online publication, further changes can only be made in the form of an Erratum, which will be hyperlinked to the article.

Online First

The article will be published online after receipt of the corrected proofs. This is the official first publication citable with the DOI. After release of the printed version, the paper can also be cited by issue and page numbers.

Open Choice 

In addition to the normal publication process (whereby an article is submitted to the journal and access to that article is granted to customers who have purchased a subscription), Springer provides an alternative publishing option: Springer Open Choice. A Springer Open Choice article receives all the benefits of a regular subscription-based article, but in addition is made available publicly through Springer’s online platform SpringerLink.

Copyright and license term – CC BY

Open Choice articles do not require transfer of copyright as the copyright remains with the author. In opting for open access, the author(s) agree to publish the article under the Creative Commons Attribution License.

English Language Editing 

For editors and reviewers to accurately assess the work presented in your manuscript you need to ensure the English language is of sufficient quality to be understood. If you need help with writing in English you should consider:
  • Asking a colleague who is a native English speaker to review your manuscript for clarity.
  • Visiting the English language tutorial which covers the common mistakes when writing in English.
  • Using a professional language editing service where editors will improve the English to ensure that your meaning is clear and identify problems that require your review. Two such services are provided by our affiliates Nature Research Editing Service and American Journal Experts.
Please note that the use of a language editing service is not a requirement for publication in this journal and does not imply or guarantee that the article will be selected for peer review or accepted.
If your manuscript is accepted it will be checked by our copyeditors for spelling and formal style before publication.

.

为便于编辑和评审专家准确评估您稿件中陈述的研究工作，您需要确保您的英语语言质量足以令人理解。如果您需要英文写作方面的帮助，您可以考虑：
● 请一位以英语为母语的同事审核您的稿件是否表意清晰。
● 查看一些有关英语写作中常见语言错误的教程。
● 使用专业语言编辑服务，编辑人员会对英语进行润色，以确保您的意思表达清晰，并识别需要您复核的问题。我们的附属机构 Nature Research Editing Service 和合作伙伴 American Journal Experts 即可提供此类服务。
请注意，使用语言编辑服务并非在期刊上发表文章的必要条件，同时也并不意味或保证文章将被选中进行同行评议或被接受。
如果您的稿件被接受，在发表之前，我们的文字编辑会检查您的文稿拼写是否规范以及文体是否正式。

.

エディターと査読者があなたの論文を正しく評価するには、使用されている英語の質が十分に高いことが必要とされます。英語での論文執筆に際してサポートが必要な場合には、次のオプションがあります：
・英語を母国語とする同僚に、原稿で使用されている英語が明確であるかをチェックしてもらう。
・英語で執筆する際のよくある間違いに関する英語のチュートリアルを参照する。
・プロの英文校正サービスを利用する。校正者が原稿の意味を明確にしたり、問題点を指摘し、英語を向上させます。Nature Research Editing Service とAmerican Journal Experts の2つは弊社と提携しているサービスです。
英文校正サービスの利用は、このジャーナルに掲載されるための条件ではないこと、また論文審査や受理を保証するものではないことに留意してください。
原稿が受理されますと、出版前に弊社のコピーエディターがスペルと体裁のチェックを行います。

.

영어 원고의 경우, 에디터 및 리뷰어들이 귀하의 원고에 실린 결과물을 정확하게 평가할 수 있도록, 그들이 충분히 이해할 수 있을 만한 수준으로 작성되어야 합니다. 만약 영작문과 관련하여 도움을 받기를 원하신다면 다음의 사항들을 고려하여 주십시오:
• 귀하의 원고의 표현을 명확히 해줄 영어 원어민 동료를 찾아서 리뷰를 의뢰합니다.
• 영어 튜토리얼 페이지에 방문하여 영어로 글을 쓸 때 자주하는 실수들을 확인합니다.
• 리뷰에 대비하여, 원고의 의미를 명확하게 해주고 리뷰에서 요구하는 문제점들을 식별해서 영문 수준을 향상시켜주는 전문 영문 교정 서비스를 이용합니다. Nature Research Editing Service와 American Journal Experts에서 저희와 협약을 통해 서비스를 제공하고 있습니다.
영문 교정 서비스는 게재를 위한 요구사항은 아니며, 해당 서비스의 이용이 피어 리뷰에 논문이 선택되거나 게재가 수락되는 것을 의미하거나 보장하지 않습니다.
원고가 수락될 경우, 출판 전 저희측 편집자에 의해 원고의 철자 및 문체를 검수하는 과정을 거치게 됩니다.

Read this Journal on Springerlink

For authors and editors

  • Aims and Scope

    Aims and Scope

    Close

    Hospital for Special Surgery is ranked # 1 in Orthopaedics and # 3 in Rheumatology by U.S. News & World Report

     The HSS Journal® is the Musculoskeletal Journal of Hospital for Special Surgery. The aim of the HSS Journal® is to promote cutting edge research, clinical pathways, and state-of-the-art techniques that inform and facilitate the continuing education of the orthopaedic and musculoskeletal communities. HSS Journal® publishes articles that offer contributions to the advancement of the knowledge of musculoskeletal diseases and encourages submission of manuscripts from all musculoskeletal disciplines.
    Click on this link to receive the Table of Contents for HSS Journal®: http://springer.com/tocsubscription/11420

  • Submit Online
  • Open Choice - Your Way to Open Access
  • Instructions for Authors

    Instructions for Authors

    Close
  • ICMJE Conflict of Interest Form
  • Compliance with Ethical Requirements

    Compliance with Ethical Requirements

    Close
  • Springer Author Academy
  • Call for Papers
  • Editor-in-Chief Disclosure Statement (pd...
  • Editorial Board Disclosures (pdf, 8.8 MB...
  • Photography Consent Form (pdf, 22 kB)
  • Modified Strobe Checklist for HSS J (doc...
  • Template for Basic Research Article (doc...
  • Template for Clinical Research Article (...
  • Template For Rheumatology-Radiology-Path...
  • Template for Survey or Review Article (d...
  • Template for Surgical Technique Article ...
  • Template for Case Reports (docx, 20 kB)
  • Author Academy: Training for Authors
  • Copyright Information

    Copyright Information

    Close

    Submission of a manuscript implies: that the work described has not been published before (except in the form of an abstract or as part of a published lecture, review or thesis); that it is not under consideration for publication elsewhere; that its publication has been approved by all coauthors, if any, as well as tacitly or explicitly by the responsible authorities at the institution where the work was carried out. Transfer of copyright to Hospital for Special Surgery becomes effective if and when the article is accepted for publication. The copyright covers the exclusive right (for U.S. government employees: to the extent transferable) to reproduce and distribute the article, including reprints, translations, photographic reproductions, microform, electronic form (offline, online) or other reproductions of similar nature.

    All articles published in this journal are protected by copyright, which covers the exclusive rights to reproduce and distribute the article (e.g., as reprints), as well as all translation rights. No material published in this journal may be reproduced photographically or stored on microfilm, in electronic data bases, video disks, etc., without first obtaining written permission from the Hospital for Special Surgery. The use of general descriptive names, trade names, trademarks, etc., in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.

    An author may self-archive an author-created version of his/her article on his/her own website. He/she may also deposit this version in any repository, provided it is not made publicly available until after 12 months of official publication. He/she may not use the publisher's PDF version which is posted on link.springer.com for the purpose of self-archiving or deposit. Furthermore, the author may only post his/her version provided acknowledgement is given to the original source of publication and a link is inserted to the published article on Springer's website. The link must be accompanied by the following text: "The original publication is available at link.springer.com".

    Please use the appropriate DOI for the article in the link. (This is designed to be a constant in the online environment. The structure of the link is http://dx.doi.org/DOIprefix/suffix; Example: http://dx.doi.org/10.1007/s00348-004-0843-x. The URL for the article appears in the Author Alert email the corresponding author receives when his/her article is first published online at SpringerLink. The DOI of the article is visible in a search result and on the article page at SpringerLink). Articles disseminated via www.springerlink.com are indexed, abstracted, and referenced by many abstracting and information services, bibliographic networks, subscription agencies, library networks, and consortia.

    While the advice and information in this journal is believed to be true and accurate at the date of its publication, neither the authors, the editors, nor can the publisher accept any legal responsibility for any errors or omissions that may be made. Springer Science + Business Media makes no warranty, express or implied, with respect to the material contained herein. Springer Science + Business Media publishes advertisements in this journal in reliance upon the responsibility of the advertiser to comply with all legal requirements relating to the marketing and sale of products or services advertised. Springer Science + Business Media and the editors are not responsible for claims made in the advertisements published in the journal. The appearance of advertisements in Springer Science + Business Media publications does not constitute endorsement, implied or intended, of the product advertised or the claims made for it by the advertiser.

    Special regulations for photocopies in the USA: Photocopies may be made for personal or in-house use beyond the limitations stipulated under Section 107 or 108 of U.S. Copyright Law, provided a fee is paid. All fees should be paid to the Copyright Clearance Center, Inc., 222 Rosewood Drive, Danvers, MA 01923, USA (Web: http://www.copyright.com; Fax: (978) 646-8600; Telephone: (978) 750-8400) stating the ISSN 1556-3316, the volume, and the first and last page numbers of each article copied. The copyright owner’s consent does not include copying for general distribution, promotion, new works, or resale. In these cases, specific written permission must first be obtained from the publisher.

    The Canada Institute for Scientific and Technical Information (CISTI) provides a comprehensive, world-wide document delivery service for all Springer Science + Business Media journals. For more information, or to place an order for a copyright-cleared Springer Science + Business Media document, please contact Client Assistant, Document Delivery, CISTI, National Research Council Canada, 1200 Montreal Road, Building M-55, Ottawa, Ontario K1A 0R6 Canada. Telephone: (613) 993-1412; Fax: (613) 941-0177; E-mail: order.cisti@nrc-cnrc.gc.ca.

    You may also contact INFOTRIEVE (Web: http://www.infotrieve.com/; E-mail: orders@infotrieve.com; Fax: (310) 208-5971; Telephone: (800) 422-4633), UnCover: http://www.ingenta.com, UMI: http://www.umi.com/ or the Institute for Scientific Information: http://www.isinet.com

    Ownership and Copyright
    © Hospital for Special Surgery

Alerts for this journal

 

Get the table of contents of every new issue published in HSS Journal ®.